Inactive Instrument
Poseida Therapeutics, Inc. Stock
Stocks
PSTX
US73730P1084
Biotechnology & Medical Research
| 1 day | -0.63% |
| 3 years | 1.83 |  | 9.67 |
| 5 years | 1.54 | | 9.67 |
| 10 years | 1.54 | | 17.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dara Pincas
CEO | Chief Executive Officer | - | - |
Johanna Mylet
DFI | Director of Finance/CFO | 39 | 01/07/2020 |
Syed Rizvi
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 08/01/2025 |
Roger Brown
BRD | Director/Board Member | - | 08/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/1/25 | Tender | Director | 190,300 | 0.1952% | ||
| 8/1/25 | Tender | Director | 141,500 | 0.1452% | ||
| 8/1/25 | Tender | Company | 11,835,673 | 12.1435% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.63% | -.--% | - | - | 929M | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +1.27% | +11.82% | +82.12% | 54.55B | |
| -1.09% | +0.74% | +10.17% | +101.67% | 53.59B | |
| +1.83% | +0.51% | +27.46% | +56.94% | 44.75B | |
| +2.08% | -3.15% | +18.13% | +100.58% | 41.62B | |
| +0.05% | -3.92% | +220.90% | +917.25% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +47.63% | +107.12% | +94.27% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +3.80% | -0.42% | +51.68% | +161.77% | 42.27B | |
| Weighted average by Cap. | +2.96% | -0.29% | +47.12% | +160.45% |
Employees
350
